Toggle navigation
Home
Search
Services
Blog
Contact
About
Treatment of Septic Shock with Mercaptoalkylguanidines
Southan, Garry John
Inotek Pharmaceuticals Corporation, Beverly, MA, United States
Search 46 grants from Garry Southan
Search grants from Inotek Pharmaceuticals Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Alcohol Stimulation and Sedation in Binge Drinkers
Intestinal satiation in Roux-en-Y gastric bypass rats: brain mechanisms and sex d
Adenovirus Limitations and Tumor Targeted Gene Therapy
Core - Serum, Lymphocyte and Tissue Collection and Analysis
Corticotropin Releasing Factor Neuroendocrine Systems
Recently added grants:
Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA model
Extracellular Vesicle Analyses to Develop Aging and Resilience Biomarkers
Diverse Homeostatic Roles for Distinct Macrophages in the Developing Lung Vasculature
Protein Kinase Novel 2 (PKN2) in heart
Acute exercise and the cerebral metabolic response in aging and Alzheimer's Disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44AI040749-02
Application #
2840834
Study Section
Special Emphasis Panel (ZRG7-SSS-8 (46))
Program Officer
Heyse, Stephen P
Project Start
1999-07-15
Project End
2001-04-30
Budget Start
1999-07-15
Budget End
2001-04-30
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Institution
Name
Inotek Pharmaceuticals Corporation
Department
Type
DUNS #
City
Beverly
State
MA
Country
United States
Zip Code
01915
Publications
Ploner, F; Radermacher, P; Theisen, M et al.
(2001)
Effects of combined selective iNOS inhibition and peroxynitrite blockade during endotoxemia in pigs.
Shock 16:130-6
Comments
Be the first to comment on Garry Southan's grant